Topical Steroids: Awareness and Misuse Among General Medical Practitioners

Authors

  • F. Hali Department of Dermatology and Venereology, Ibn Rochd University Hospital, Casablanca, Morocco
  • S. Zakaryaa Department of Dermatology and Venereology, Ibn Rochd University Hospital, Casablanca, Morocco
  • S. Chiheb Department of Dermatology and Venereology, Ibn Rochd University Hospital, Casablanca, Morocco

DOI:

https://doi.org/10.14738/bjhmr.102.14440

Keywords:

general medical practitioners, misuse, use, awareness, topical steroids

Abstract

Introduction: Topical steroids (TS) contributed in the management of several inflammatory, tumoral or allergic dermatoses. However, their misuse may lead to serious or even irreversible adverse effects. This study aimed to evaluate the knowledge and attitudes of general medical practitioners in Morocco regarding topical steroids use and misuse. Materials and Methods: Cross-sectional national survey over a 4-month period from 01/09/2022 to 30/12/2022. The data was collected by a Google Forms questionnaire which was shared on different professional groups on the social networks. The target population was Moroccan general practitioners. Data analysis was performed by Excel software. Results: A total of 200 general medical practitioners answered the questionnaire, of which 133(66.5%) practiced in the public sector and 67(33.5%) in the private sector. 11% had rated their frequency of prescription as high, 56% as medium and 33% as minimal or rare; the indications were dominated by eczema, atopic dermatitis and psoriasis. The prescription of topical corticosteroids started from the age of 1 year in 32.5% of general practitioners while the majority prescribed them at any age. Sixty (30%) were aware of the pharmacological effects of topical corticosteroids. The most frequently prescribed galenic form was cream in 95% of cases followed by gels, lotions and finally preparations. One hundred and thirty-three (66%) had answered correctly to the indications of topical corticosteroids and 106(53%) prescribed them in short cures. Few doctors (1%) had been able to identify all side effects. One hundred and fifty (75%) of the general medical practitioners had already seen patients presenting adverse effects dominated by skin atrophy, delayed healing, depigmentation, fungal or bacterial infection; their response consisted of degression in 75% of cases or switching to a lower class, while 11.5% had wrongly suggested an abrupt discontinuation. Conclusion: The high frequency of topical steroids side effects is an increasing problem encountered by dermatologists. Lack of some general practitioners and patient awareness are also important underlying factors. To our knowledge, this is the first Moroccan study that aimed to evaluate the knowledge, attitudes, and behavior regarding topical corticosteroids by general medical practitioners.

References

Kumar S, Goyal A, Gupta YK. Abuse of topical corticosteroids in India: Concerns and the way forward. J Pharmacol Pharmacother 2016; 7:1-5.

Niral K. Sheth, Pragya Ashok Nair Topical steroids: Awareness and misuse among patients, pharmacists and general medical practitioner. Indian Journal of Dermatology, Venereology and Leprology 2021; 87:1.

Joshi,1 Sajana Bhandari, Shristi Shrestha,1 Smita. Prevalence of Misuse of Topical Corticosteroid among Dermatology Outpatients. J Nepal Med Assoc 2020;58(231):834-8.

Srivastava A. A clinic epidemiological study of topical corticosteroid misuse at a tertiary care center. J Dermatolog Treat. 2019 Nov;30(7):685-690.

Meena S, Gupta LK, Khare AK, Balai M, Mittal A, Mehta S, et al. Topical Corticosteroids Abuse: A Clinical Study of Cutaneous Adverse Effects. Indian J Dermatol. 2017 Nov-Dec;62(6):675.

Thomas M, Wong CC, Anderson P, Grills N. Magnitude, characteristics and consequences of topical steroid misuse in rural North India: an observational study among dermatology outpatients. BMJ Open. 2020 May 18;10(5): e032829.

Chaudhary RG, Rathod SP, Jagati A, Baxi K, Ambasana A, Patel D. Prescription and Usage Pattern of Topical Corticosteroids among Out-patient Attendees with Dermatophyte Infections and Its Analysis: A Cross-sectional, Survey-based Study. Indian Dermatol Online J. 2019 May-Jun;10(3):279-283.

Nagesh TS, Akhilesh A. Topical steroid awareness and abuse: A prospective study among dermatology outpatients. Indian J Dermatol 2016;61: 618-21. 10.

Jha AK, Sinha R, Prasad S. Misuse of topical corticosteroids on the face: A cross-sectional study among dermatology outpatients. Indian Dermatol Online J 2016; 7:259-63.

Karalikkattil T. Ashique, Feroze Kaliyadan, Shilpa Mohan, Shreya Vijayan, Dilip Chandrasekhar. Knowledge, Attitudes and Behavior Regarding Topical Corticosteroids in a Sample of Pharmacy Students: A Cross Sectional Survey. Indian J Dermatol 2018; 9: 6.

Farrugia LL, Lee A, Fischer G, Blaszczynski A, Carter SR, Smith SD, et al. Evaluation of the influence of pharmacists and GPs on patient perceptions of long-term topical corticosteroid use. J Dermatolog Treat 2017; 28:112-8.

Downloads

Published

2023-04-24

How to Cite

Hali, F., Zakaryaa, S., & Chiheb, S. (2023). Topical Steroids: Awareness and Misuse Among General Medical Practitioners. British Journal of Healthcare and Medical Research, 10(2), 421–425. https://doi.org/10.14738/bjhmr.102.14440